Assessment of renal involvement in patients with systemic lupus erythematosus in a tertiary care hospital
Keywords:Clinico-pathological correlation, Lupus nephritis, Systemic lupus erythematosus
Background: Renal involvement in SLE is common. Lupus Nephritis is the major cause of mortality in SLE patients. Renal involvement is a severe form of the disease and subsequent management is planned according to the histopathological class of lupus nephritis. Thus, this study was planned to assess the clinical profile and the extent of renal disease in SLE patients.
Methods: A prospective observational study was conducted among SLE patients who got admitted in the Department of General Medicine and Nephrology in Thanjavur Medical College Hospital, Thanjavur from July 2012 to October 2013. Fifty SLE patients who had renal symptoms were included in this study.
Results: SLE is Common among females. Common renal presentations were haematuria and proteinuria. 42% of the patients had Class IV lupus nephritis, followed by 24%, 16%, 16%, and 2% of Class III, II, Class V and Class I lupus nephritis respectively. No case of class VI lupus nephritis was reported in this study. ANA was positive among 66%, Anti ds DNA was positive in 64% and C3 level was found to be reduced in 50% of patients. Antiphospholipid antibodies were seen in 2% of the patients.
Conclusions: Proteinuria, haematuria, a lower serum C3 level and need for aggressive hypertension management were prominently seen with a worse class of lupus nephritis. Patients with active and proliferative forms of lupus nephritis had a severe course of illness and required aggressive management with immunosuppressants.
Appel GB, Silva FG, Pirani CL, Meltzer JI, Estes D. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Med. 1978;57(5):371-410.
Zonana-Nacach A, Roseman JM, McGwin Jr G, Friedman AW, Baethge BA, Reveille JD. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. Lupus. 2000;9(2):101-9.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatism Off J Am Coll Rheumatol. 1997;40(9):1725.
Ortega LM, Schultz DR, Lenz O. Review: Lupus. Epidemiol Lupus. 2010;19:557.
Feldman CH, Hiraki LT, Liu J, Fischer MA, Solomon DH, Alarcón GS, et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheumat. 2013;65(3):753-63.
Rothfield NF, McCluskey RT, Baldwin DS. Renal disease in systemic lupus erythematosus. N Engl J Med. 1963;269:53
Weening JJ, D'agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521-30.
Rahman A, Isenberg DA. Review article: systemic lupus erythematosus. N Engl J Med. 2008;358.
Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15(5):308-18.
Weinstein A, Bordwell B, Stone B, Tibbetts C, Rothfield NF. Antibodies to native DMA and serum complement (C3) levels: Application to diagnosis and classification of systemic lupus erythematosus. Am J Med. 1983;74(2):206-16.
Striker GE, Kelly MR, Quadracci LJ, Scribner BH. The course of lupus nephritis: a clinical-pathological correlation of fifty patients. Perspect Nephrol Hypertens. 1973;1:1141.